Literature DB >> 8956798

Survival of classic Kaposi's sarcoma and risk of second cancer.

S Franceschi1, S Arniani, D Balzi, M Geddes.   

Abstract

In order to elucidate survival rates and risk of second primary cancer, we assessed 204 patients with histologically confirmed classic Kaposi's sarcoma (KS) who were identified in 11 Italian population-based cancer registries. One hundred and thirty-nine were men (median age 70 years) and 65 were women (median age 72). One, 5 and 10 year survival rates were 0.92, 0.69 and 0.46 respectively. Median survival was 9.4 years (i.e. not different from the Italian general population of the same sex and age). Survival did not vary according to sex and tumour site (i.e. lower limbs only or other). Eleven second primary cancers, including two lung and two kidney cancers, were reported after KS diagnosis (not different from the expected number).

Entities:  

Mesh:

Year:  1996        PMID: 8956798      PMCID: PMC2077228          DOI: 10.1038/bjc.1996.635

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

Review 1.  Cancer registration: principles and methods. Analysis of survival.

Authors:  D M Parkin; T Hakulinen
Journal:  IARC Sci Publ       Date:  1991

2.  Epidemiology of Kaposi's sarcoma in Sweden prior to the acquired immunodeficiency syndrome.

Authors:  M Dictor; R Attewell
Journal:  Int J Cancer       Date:  1988-09-15       Impact factor: 7.396

3.  Association of Kaposi's sarcoma with second primary malignancies: possible etiopathogenic implications.

Authors:  B Safai; V Miké; G Giraldo; E Beth; R A Good
Journal:  Cancer       Date:  1980-03-15       Impact factor: 6.860

4.  Kaposi's sarcoma in Colombia.

Authors:  A García; F Olivella; S Valderrama; G Rodríguez
Journal:  Cancer       Date:  1989-12-01       Impact factor: 6.860

5.  Prognosis in Kaposi's sarcoma.

Authors:  A C Templeton; D Bhana
Journal:  J Natl Cancer Inst       Date:  1975-12       Impact factor: 13.506

6.  Changing patterns of Kaposi's sarcoma in Danish acquired immunodeficiency syndrome patients with complete follow-up. The Danish Study Group for HIV Infection (DASHI).

Authors:  J D Lundgren; M Melbye; C Pedersen; P S Rosenberg; J Gerstoft
Journal:  Am J Epidemiol       Date:  1995-04-01       Impact factor: 4.897

7.  Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone.

Authors:  Y Lunardi-Iskandar; J L Bryant; R A Zeman; V H Lam; F Samaniego; J M Besnier; P Hermans; A R Thierry; P Gill; R C Gallo
Journal:  Nature       Date:  1995-05-04       Impact factor: 49.962

Review 8.  Lymphoproliferative disorders in non-AIDS-associated Kaposi's sarcoma. The Johannesburg Hospital experience, 1980-1992.

Authors:  M E Stein; D Spencer; R Dansey; Y Perner; K Gunther; W R Bezwoda
Journal:  S Afr Med J       Date:  1994-08

Review 9.  Kaposi's sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy.

Authors:  J W Tappero; M A Conant; S F Wolfe; T G Berger
Journal:  J Am Acad Dermatol       Date:  1993-03       Impact factor: 11.527

10.  Mediterranean Kaposi's sarcoma in the elderly. A randomized study of oral etoposide versus vinblastine.

Authors:  L Brambilla; R Labianca; V Boneschi; S Fossati; G Dallavalle; A F Finzi; G Luporini
Journal:  Cancer       Date:  1994-11-15       Impact factor: 6.860

View more
  2 in total

1.  Cause-specific mortality in classic Kaposi's sarcoma: a population-based study in Italy (1995-2002).

Authors:  V Ascoli; G Minelli; M Kanieff; R Crialesi; L Frova; S Conti
Journal:  Br J Cancer       Date:  2009-08-25       Impact factor: 7.640

2.  Quadruple Multiple Primary Malignancies: Early Detection of Second Primary Malignancy by Esophagogastroduodenoscopy/Colonoscopy Is Crucial for Patients with Classic Kaposi's Sarcoma.

Authors:  Nobuyuki Maruyama; Yuko Okubo; Masato Umikawa; Akiko Matsuzaki; Akira Hokama; Fusahiro Hirano; Tessho Maruyama; Kazuhide Nishihara; Toshiyuki Nakasone; Shoko Makishi; Hiroyuki Nakamura; Naoki Yoshimi
Journal:  Diagnostics (Basel)       Date:  2020-04-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.